3rd Quarter - Report

MEDLINE for MEDLINE

Period 3rd Quarter 2012 Filed Oct 15, 2012 Signed by Robert Calia, Government Affairs Specialist

Official filing
Firm
MEDLINE
Client
MEDLINE
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the FDA. Issues related to medical devices, including the Unique Device Identification System Proposed Rule; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).

LobbyistCovered position, as disclosed
ROBERT CALIA Confidential Assistant, Department of Commerce

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 4395 (112th), S. 17 (112th), H.R. 4262 (112th), S. 262 (112th), H.R. 436 (112th), H.R. 2359 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.